Cargando…

Leukotriene Receptor Antagonists Inhibit Mitogenic Activity in Triple Negative Breast Cancer Cells

Despite a discovery of hormonal pathways regulating breast cancer, a definitive cure for the disease requires further identification of alternative targets that provide a hormone-independent support. Apart from their role in inflammatory diseases, cysteinyl leukotriene (CysLT) receptor antagonists (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suknuntha, Kran, Yubolphan, Ruedeemars, Krueaprasertkul, Kanokpan, Srihirun, Sirada, Sibmooh, Nathawut, Vivithanaporn, Pornpun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980863/ https://www.ncbi.nlm.nih.gov/pubmed/29582642 http://dx.doi.org/10.22034/APJCP.2018.19.3.833

Ejemplares similares

Increased platelet activation and lower platelet-monocyte aggregates in COVID-19 patients with severe pneumonia
por: Srihirun, Sirada, et al.
Publicado: (2023)

Phosphorylated vasodilator-stimulated phosphoprotein (P-VASP(Ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes
por: Srihirun, Sirada, et al.
Publicado: (2018)

Platelet Inhibition by Nitrite Is Dependent on Erythrocytes and Deoxygenation
por: Srihirun, Sirada, et al.
Publicado: (2012)

Decreased nitrite reductase activity of deoxyhemoglobin correlates with platelet activation in hemoglobin E/ß-thalassemia subjects
por: Chamchoi, Attaphon, et al.
Publicado: (2018)

Leukotriene Antagonists in Dermatology
por: Bubna, Aditya Kumar
Publicado: (2021)

Ethanolic extract of Halymenia durvillei induced G2/M arrest and altered the levels of cell cycle regulatory proteins of MDA-MB-231 triple-negative breast cancer cells
por: Settacomkul, Rapeewan, et al.
Publicado: (2023)

Onion Peel Extract Inhibits Cancer Cell Growth and Progression through the Roles of L1CAM, NF-κB, and Angiogenesis in HT-29 Colorectal Cancer Cells
por: Uttarawichien, Tamonwan, et al.
Publicado: (2021)

Platelet inhibitory effects of juices from Pachyrhizus erosus L. root and Psidium guajava L. fruit: a randomized controlled trial in healthy volunteers
por: Thaptimthong, Thitiporn, et al.
Publicado: (2016)

Churg-Strauss syndrome associated with leukotriene receptor antagonists.
por: McAuley, D. F., et al.
Publicado: (2001)

Side effects of the leukotriene receptor antagonists in asthmatic children
por: Can, Demet, et al.
Publicado: (2015)

Side Effects of Leukotriene Receptor Antagonists in Asthmatic Children
por: Erdem, Semiha Bahceci, et al.
Publicado: (2015)

A Flow Cytometric Analysis of the Inhibition of Platelet Reactivity Due to Nitrite Reduction by Deoxygenated Erythrocytes
por: Akrawinthawong, Krittapoom, et al.
Publicado: (2014)

Update on leukotriene receptor antagonists in preschool children wheezing disorders
por: Montella, Silvia, et al.
Publicado: (2012)

Leukotriene receptor antagonists for chronic urticaria: a systematic review
por: de Silva, Nipun Lakshitha, et al.
Publicado: (2014)

Montelukast: More than a Cysteinyl Leukotriene Receptor Antagonist?
por: Tintinger, Gregory R., et al.
Publicado: (2010)

Anti-Migration and Invasion Effects of Astaxanthin against A172 Human Glioblastoma Cell Line
por: Siangcham, Tanapan, et al.
Publicado: (2020)

Cysteinyl Leukotrienes and Uridine Diphosphate Induce Cytokine Generation by Human Mast Cells Through an Interleukin 4–regulated Pathway that Is Inhibited by Leukotriene Receptor Antagonists
por: Mellor, Elizabeth A., et al.
Publicado: (2002)

Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA shedding
por: Arai, Jun, et al.
Publicado: (2020)

Exercise-induced bronchoconstriction: The effects of montelukast, a leukotriene receptor antagonist
por: Kemp, James P
Publicado: (2009)

Protection of leukotriene receptor antagonist against aspirin-induced bronchospasm in asthmatics
por: Park, Jong Sook, et al.
Publicado: (2010)

Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
por: Tsai, Ming-Ju, et al.
Publicado: (2016)

The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic
por: Aigner, Ludwig, et al.
Publicado: (2020)

MK-571, a Cysteinyl Leukotriene Receptor 1 Antagonist, Inhibits Hepatitis C Virus Replication
por: Ruiz, Isaac, et al.
Publicado: (2020)

Biocompatibility and biofilm formation on conventional and CAD/CAM provisional implant restorations
por: Parakaw, Tipparat, et al.
Publicado: (2023)

The linkage between Churg-Strauss syndrome and leukotriene receptor antagonists: fact or fiction?
por: McDanel, Deanna L, et al.
Publicado: (2005)

Role of Leukotriene Receptor Antagonists in the Treatment of Exercise-Induced Bronchoconstriction: A Review
por: Philteos, George S, et al.
Publicado: (2005)

Cysteinyl Leukotriene Receptor-1 Antagonists as Modulators of Innate Immune Cell Function
por: Theron, A. J., et al.
Publicado: (2014)

Corrigendum: Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
por: Tsai, Ming-Ju, et al.
Publicado: (2016)

Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
por: Wallin, Johan, et al.
Publicado: (2021)

Is Leukotriene Receptor Antagonist the Direct Cause of Churg-Strauss Syndrome in Asthmatic Patients?
por: Paul, Salomi, et al.
Publicado: (2022)

Use of Leukotriene-Receptor Antagonists During Pregnancy and Risk of Neuropsychiatric Events in Offspring
por: Tsai, Hui-Ju, et al.
Publicado: (2023)

The Employment of Leukotriene Antagonists in Cutaneous Diseases Belonging to Allergological Field
por: Nettis, Eustachio, et al.
Publicado: (2010)

StemRegenin 1 selectively promotes expansion of Multipotent Hematopoietic Progenitors derived from Human Embryonic Stem Cells
por: Tao, Lihong, et al.
Publicado: (2017)

170 Combination of a Nasal Antihistamine Olopatadine and A Leukotriene Receptor Antagonist Montelukast Sodium for the Treatment of Seasonal Allergic Patients not Currently Controlled on Monotherapy Intranasal Antihistamine or a Leukotriene Receptor Antagonist
por: Nsouli, Safa
Publicado: (2012)

Increased fluidity and oxidation of malarial lipoproteins: relation with severity and induction of endothelial expression of adhesion molecules
por: Sibmooh, Nathawut, et al.
Publicado: (2004)

Megakaryocytic Expansion in Gilteritinib-Treated Acute Myeloid Leukemia Patients Is Associated With AXL Inhibition
por: Suknuntha, Kran, et al.
Publicado: (2020)

195 The Impact of Administration of Leukotriene Receptor Antagonists, Pranlukast-EK to Infants with Bronchial Asthma
por: Ogawa, Norifumi, et al.
Publicado: (2012)

Structure based virtual screening of ligands to identify cysteinyl leukotriene receptor 1 antagonist
por: Bandaru, Srinivas, et al.
Publicado: (2014)

Adverse drug reactions of leukotriene receptor antagonists in children with asthma: a systematic review
por: Dixon, Eleanor Grace, et al.
Publicado: (2021)

BLT2, a leukotriene B(4) receptor 2, as a novel prognostic biomarker of triple-negative breast cancer
por: Park, JaeIn, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2c0t5dn121f3gri6u3ljqoi18b